- Home
- MNRO
MNRO
Monro Inc.
as 08-22-2025 4:00pm EST
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
| Founded: | 1957 | Country: | United States |
| Employees: | N/A | City: | FAIRPORT |
| Market Cap: | 481.5M | IPO Year: | 1991 |
| Target Price: | $20.75 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.20 - $30.18 | Next Earning Date: | 07-30-2025 |
| Revenue: | $1,203,187,000 | Revenue Growth: | -3.20% |
| Revenue Growth (this year): | 1.31% | Revenue Growth (next year): | 2.56% |
Latest Monro Inc. News
MNRO Breaking Stock News: Dive into MNRO Ticker-Specific Updates for Smart Investing
Argus Research
2 months ago
MNRO: What does Argus have to say about MNRO?
StockStory
2 months ago
3 Reasons MNRO is Risky and 1 Stock to Buy Instead
Business Wire
2 months ago
Monro, Inc. Publishes Fifth Annual Environmental, Social, and Governance (ESG) Report
StockStory
2 months ago
Monro, Edgewell Personal Care, Caleres, Caesars Entertainment, and Wolverine Worldwide Shares Plummet, What You Need To Know
StockStory
2 months ago
3 Hyped Up Stocks Skating on Thin Ice
StockStory
2 months ago
Auto Parts Retailer Stocks Q1 In Review: Monro (NASDAQ:MNRO) Vs Peers
Argus Research
2 months ago
MNRO: What does Argus have to say about MNRO?
Business Wire
2 months ago
Monro, Inc. Appoints Kathryn Chang as Senior Vice President of Merchandising
Compare MNRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MNRO Monro Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.